Motions for summary judgment filed in lawsuit challenging claim and continuation rulesDecember 21, 2007

Yesterday the parties filed their motions for summary judgment in the cases brought by GlaxoSmithKline (GSK) and Dr. Tafas challenging the USPTO's new claim and continuation limit rules. Apparently the earlier order setting the deadline for amicus briefs did not apply to the parties' motions, as earlier speculated. The deadline for briefs in opposition is January 22.

More amici have also joined in, including the first group supporting the USPTO. Click below for links to the filings. Once we've had a chance to review them, we'll post our thoughts.

Motions for summary judgment

• USPTO
  • Motion for summary judgment against Tafas
  • Motion for summary judgment against GSK
  • Brief in support of both motions
• Tafas
  • Motion for summary judgment
  • Brief in support
• GSK
  • Motion for summary judgment
  • Brief in support

Filings relating to amici

• Supporting plaintiffs
  • Cantor Fitzgerald Patent Holdings, LLC (motion for leave)
  • CropLife America (motion for leave)
  • Fédération Internationale Des Conseils En Propriété Industrielle (motion for leave)
  • Valspar Corporation, General Mills, Inc., Donaldson Company, Inc., Ecolab Inc., and Anchor Wall Systems, Inc. (motion for leave)
• Supporting defendants
  • Micron Technology (motion for leave, proposed brief)
  • Public Patent Foundation, Computer & Communications Industry Association, AARP, Consumer Federation of America, Essential Action, Foundation for Taxpayer and Consumer Rights, Initiative for Medicines, Access & Knowledge, Knowledge Ecology International, Prescription Access Litigation, Public Knowledge, Research on Innovation, and Software Freedom Law Center (motion for leave, proposed brief)